MEEDER ASSET MANAGEMENT INC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 103 filers reported holding REVANCE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.7%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$130,000
+217.1%
5,241
+94.2%
0.01%
+166.7%
Q1 2020$41,000
+57.7%
2,699
+66.3%
0.00%
+50.0%
Q4 2019$26,000
+85.7%
1,623
+55.6%
0.00%
+100.0%
Q3 2019$14,000
+16.7%
1,043
+69.9%
0.00%0.0%
Q4 2018$12,000
+140.0%
614
+383.5%
0.00%
Q4 2017$5,000
-54.5%
127
-74.9%
0.00%
-100.0%
Q1 2017$11,000
-31.2%
505
-33.5%
0.00%
-50.0%
Q4 2016$16,0007590.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders